The role of Thr160 phosphorylation of Cdk2 in substrate recognition

J K Holmes1, M J Solomon

  • 1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8114, USA.

Insights

Activating phosphorylation of cyclin-dependent kinases (Cdks) at Thr160 is crucial for substrate recognition. This phosphorylation enhances catalysis by facilitating an ionic interaction with the substrate

Area of Science:

  • Molecular Biology
  • Enzymology
  • Protein Kinase Signaling

Background:

  • Cyclin-dependent kinases (Cdks) require cyclin binding and activating phosphorylation for full activity.
  • The precise role of activating phosphorylation, specifically at Thr160 in Cdk2, remains less understood compared to cyclin binding effects.

Purpose of the Study:

  • To investigate the impact of Thr160 phosphorylation on Cdk2's substrate interactions, focusing on the P + 3 position.
  • To elucidate the mechanistic contribution of the Thr160 phosphate group in substrate binding and catalysis.

Main Methods:

  • Biochemical characterization of Cdk2 phosphorylation.
  • Analysis of substrate interactions, including kinetic parameter determination (Km and kcat).
  • Structural insights into Cdk2-substrate complexes.

Main Results:

  • An ionic interaction between the substrate's P + 3 lysine residue and the Cdk2 Thr160 phosphate was identified.
  • Disruption of this lysine-phosphate interaction primarily affected catalytic rates (kcat) rather than substrate binding affinity (Km).
  • Thr160 phosphorylation did not significantly alter Cdk2's ATPase activity, supporting a role in substrate alignment for catalysis.

Conclusions:

  • The Thr160 phosphate of Cdk2 plays a key role in substrate recognition through an ionic interaction at the P + 3 position.
  • This interaction contributes energy to substrate alignment, enhancing catalytic efficiency (kcat) rather than substrate binding (Km).
  • Activating phosphorylation of Cdk2 is essential for optimizing substrate processing through precise positioning for catalysis.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...